nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—CYP2C9—brain cancer	0.809	1	CbGaD
Salicylic acid—PTGS2—Etoposide—brain cancer	0.0242	0.46	CbGbCtD
Salicylic acid—PTGS1—Etoposide—brain cancer	0.0204	0.388	CbGbCtD
Salicylic acid—SLC22A8—choroid plexus—brain cancer	0.0126	0.252	CbGeAlD
Salicylic acid—ABCB1—Etoposide—brain cancer	0.00798	0.152	CbGbCtD
Salicylic acid—Lethargy—Lomustine—brain cancer	0.00265	0.0356	CcSEcCtD
Salicylic acid—SLCO2B1—ganglion—brain cancer	0.00262	0.0524	CbGeAlD
Salicylic acid—Hearing impaired—Procarbazine—brain cancer	0.00239	0.032	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—TP53—brain cancer	0.00232	0.497	CrCbGaD
Salicylic acid—Burning sensation—Carmustine—brain cancer	0.00205	0.0274	CcSEcCtD
Salicylic acid—Deafness—Procarbazine—brain cancer	0.00184	0.0247	CcSEcCtD
Salicylic acid—Lethargy—Procarbazine—brain cancer	0.00168	0.0226	CcSEcCtD
Salicylic acid—Skin exfoliation—Hydroxyurea—brain cancer	0.00168	0.0225	CcSEcCtD
Salicylic acid—Hearing impaired—Temozolomide—brain cancer	0.00144	0.0194	CcSEcCtD
Salicylic acid—PTGS1—ganglion—brain cancer	0.00136	0.0273	CbGeAlD
Salicylic acid—Skin exfoliation—Carmustine—brain cancer	0.00136	0.0182	CcSEcCtD
Salicylic acid—Skin exfoliation—Temozolomide—brain cancer	0.00131	0.0176	CcSEcCtD
Salicylic acid—Drowsiness—Procarbazine—brain cancer	0.00127	0.017	CcSEcCtD
Salicylic acid—Pain—Carboplatin—brain cancer	0.00125	0.0167	CcSEcCtD
Salicylic acid—Anorexia—Lomustine—brain cancer	0.00122	0.0163	CcSEcCtD
Salicylic acid—Epistaxis—Procarbazine—brain cancer	0.0012	0.0161	CcSEcCtD
Salicylic acid—Mefenamic acid—CYP2C9—brain cancer	0.00119	0.254	CrCbGaD
Salicylic acid—PTGS1—endothelium—brain cancer	0.00118	0.0236	CbGeAlD
Salicylic acid—SLC16A1—telencephalon—brain cancer	0.00117	0.0235	CbGeAlD
Salicylic acid—Acetylsalicylic acid—CYP2C9—brain cancer	0.00116	0.248	CrCbGaD
Salicylic acid—Hallucination—Procarbazine—brain cancer	0.00114	0.0152	CcSEcCtD
Salicylic acid—PTGS2—endothelium—brain cancer	0.00112	0.0225	CbGeAlD
Salicylic acid—Deafness—Temozolomide—brain cancer	0.00111	0.015	CcSEcCtD
Salicylic acid—Decreased appetite—Lomustine—brain cancer	0.00111	0.0149	CcSEcCtD
Salicylic acid—PTGS1—blood vessel—brain cancer	0.00108	0.0217	CbGeAlD
Salicylic acid—Skin exfoliation—Etoposide—brain cancer	0.00105	0.0141	CcSEcCtD
Salicylic acid—PTGS2—blood vessel—brain cancer	0.00104	0.0208	CbGeAlD
Salicylic acid—SLCO2B1—telencephalon—brain cancer	0.00101	0.0202	CbGeAlD
Salicylic acid—Oesophagitis—Etoposide—brain cancer	0.001	0.0135	CcSEcCtD
Salicylic acid—Weight increased—Hydroxyurea—brain cancer	0.001	0.0135	CcSEcCtD
Salicylic acid—SLC22A11—endocrine gland—brain cancer	0.000992	0.0199	CbGeAlD
Salicylic acid—Drowsiness—Hydroxyurea—brain cancer	0.000984	0.0132	CcSEcCtD
Salicylic acid—SLC16A1—gonad—brain cancer	0.000979	0.0196	CbGeAlD
Salicylic acid—SLC22A7—endocrine gland—brain cancer	0.000968	0.0194	CbGeAlD
Salicylic acid—SLC16A1—pituitary gland—brain cancer	0.000955	0.0191	CbGeAlD
Salicylic acid—SLC16A1—medulla oblongata—brain cancer	0.000922	0.0185	CbGeAlD
Salicylic acid—Hallucination—Hydroxyurea—brain cancer	0.000879	0.0118	CcSEcCtD
Salicylic acid—SLC16A1—midbrain—brain cancer	0.000843	0.0169	CbGeAlD
Salicylic acid—SLC16A1—spinal cord—brain cancer	0.000822	0.0165	CbGeAlD
Salicylic acid—Confusional state—Procarbazine—brain cancer	0.000817	0.011	CcSEcCtD
Salicylic acid—Vomiting—Lomustine—brain cancer	0.000812	0.0109	CcSEcCtD
Salicylic acid—Oedema—Procarbazine—brain cancer	0.000811	0.0109	CcSEcCtD
Salicylic acid—SLCO2B1—medulla oblongata—brain cancer	0.000793	0.0159	CbGeAlD
Salicylic acid—Weight increased—Temozolomide—brain cancer	0.000784	0.0105	CcSEcCtD
Salicylic acid—Anorexia—Procarbazine—brain cancer	0.000773	0.0104	CcSEcCtD
Salicylic acid—Erythema—Hydroxyurea—brain cancer	0.000769	0.0103	CcSEcCtD
Salicylic acid—Nausea—Lomustine—brain cancer	0.000758	0.0102	CcSEcCtD
Salicylic acid—SLC16A1—endocrine gland—brain cancer	0.00074	0.0148	CbGeAlD
Salicylic acid—SLC16A1—head—brain cancer	0.000731	0.0146	CbGeAlD
Salicylic acid—Somnolence—Procarbazine—brain cancer	0.000721	0.00967	CcSEcCtD
Salicylic acid—Hallucination—Carmustine—brain cancer	0.00071	0.00953	CcSEcCtD
Salicylic acid—SLCO2B1—spinal cord—brain cancer	0.000707	0.0142	CbGeAlD
Salicylic acid—Decreased appetite—Procarbazine—brain cancer	0.000705	0.00945	CcSEcCtD
Salicylic acid—Pain—Procarbazine—brain cancer	0.000693	0.0093	CcSEcCtD
Salicylic acid—Constipation—Procarbazine—brain cancer	0.000693	0.0093	CcSEcCtD
Salicylic acid—SLC22A7—brain—brain cancer	0.000692	0.0139	CbGeAlD
Salicylic acid—Hepatitis—Temozolomide—brain cancer	0.00069	0.00925	CcSEcCtD
Salicylic acid—Hallucination—Temozolomide—brain cancer	0.000686	0.00921	CcSEcCtD
Salicylic acid—SLC22A6—brain—brain cancer	0.000668	0.0134	CbGeAlD
Salicylic acid—Feeling abnormal—Procarbazine—brain cancer	0.000668	0.00896	CcSEcCtD
Salicylic acid—SLC16A1—central nervous system—brain cancer	0.000667	0.0134	CbGeAlD
Salicylic acid—Erythema multiforme—Temozolomide—brain cancer	0.000652	0.00875	CcSEcCtD
Salicylic acid—SLC16A1—cerebellum—brain cancer	0.000652	0.013	CbGeAlD
Salicylic acid—Urticaria—Procarbazine—brain cancer	0.000644	0.00864	CcSEcCtD
Salicylic acid—Tinnitus—Temozolomide—brain cancer	0.000643	0.00863	CcSEcCtD
Salicylic acid—ABCB1—blood vessel—brain cancer	0.000641	0.0128	CbGeAlD
Salicylic acid—SLCO2B1—endocrine gland—brain cancer	0.000637	0.0127	CbGeAlD
Salicylic acid—SLCO2B1—head—brain cancer	0.000629	0.0126	CbGeAlD
Salicylic acid—Oedema—Hydroxyurea—brain cancer	0.000627	0.00842	CcSEcCtD
Salicylic acid—Erythema—Carmustine—brain cancer	0.000621	0.00834	CcSEcCtD
Salicylic acid—Erythema—Temozolomide—brain cancer	0.000601	0.00806	CcSEcCtD
Salicylic acid—Anorexia—Hydroxyurea—brain cancer	0.000598	0.00802	CcSEcCtD
Salicylic acid—Dysgeusia—Temozolomide—brain cancer	0.000588	0.00789	CcSEcCtD
Salicylic acid—SLCO2B1—central nervous system—brain cancer	0.000574	0.0115	CbGeAlD
Salicylic acid—Pruritus—Procarbazine—brain cancer	0.000574	0.00769	CcSEcCtD
Salicylic acid—SLCO2B1—cerebellum—brain cancer	0.000561	0.0112	CbGeAlD
Salicylic acid—Somnolence—Hydroxyurea—brain cancer	0.000558	0.00748	CcSEcCtD
Salicylic acid—Diarrhoea—Procarbazine—brain cancer	0.000555	0.00744	CcSEcCtD
Salicylic acid—Dyspepsia—Hydroxyurea—brain cancer	0.000552	0.00741	CcSEcCtD
Salicylic acid—SLC22A8—head—brain cancer	0.000552	0.0111	CbGeAlD
Salicylic acid—Decreased appetite—Hydroxyurea—brain cancer	0.000545	0.00732	CcSEcCtD
Salicylic acid—Pain—Hydroxyurea—brain cancer	0.000536	0.0072	CcSEcCtD
Salicylic acid—Constipation—Hydroxyurea—brain cancer	0.000536	0.0072	CcSEcCtD
Salicylic acid—Dizziness—Procarbazine—brain cancer	0.000536	0.00719	CcSEcCtD
Salicylic acid—SLC16A1—brain—brain cancer	0.000529	0.0106	CbGeAlD
Salicylic acid—PTGS1—telencephalon—brain cancer	0.000526	0.0105	CbGeAlD
Salicylic acid—Erythema multiforme—Etoposide—brain cancer	0.000522	0.007	CcSEcCtD
Salicylic acid—Feeling abnormal—Hydroxyurea—brain cancer	0.000517	0.00693	CcSEcCtD
Salicylic acid—Vomiting—Procarbazine—brain cancer	0.000515	0.00691	CcSEcCtD
Salicylic acid—Confusional state—Carmustine—brain cancer	0.000511	0.00686	CcSEcCtD
Salicylic acid—Rash—Procarbazine—brain cancer	0.000511	0.00686	CcSEcCtD
Salicylic acid—Dermatitis—Procarbazine—brain cancer	0.000511	0.00685	CcSEcCtD
Salicylic acid—Headache—Procarbazine—brain cancer	0.000508	0.00681	CcSEcCtD
Salicylic acid—Oedema—Carmustine—brain cancer	0.000507	0.0068	CcSEcCtD
Salicylic acid—SLC22A8—central nervous system—brain cancer	0.000504	0.0101	CbGeAlD
Salicylic acid—PTGS2—telencephalon—brain cancer	0.000503	0.0101	CbGeAlD
Salicylic acid—Confusional state—Temozolomide—brain cancer	0.000494	0.00663	CcSEcCtD
Salicylic acid—Oedema—Temozolomide—brain cancer	0.00049	0.00657	CcSEcCtD
Salicylic acid—Anorexia—Carmustine—brain cancer	0.000483	0.00648	CcSEcCtD
Salicylic acid—Nausea—Procarbazine—brain cancer	0.000482	0.00646	CcSEcCtD
Salicylic acid—Dysgeusia—Etoposide—brain cancer	0.000471	0.00631	CcSEcCtD
Salicylic acid—Anorexia—Temozolomide—brain cancer	0.000467	0.00627	CcSEcCtD
Salicylic acid—SLCO2B1—brain—brain cancer	0.000455	0.00912	CbGeAlD
Salicylic acid—Somnolence—Carmustine—brain cancer	0.000451	0.00605	CcSEcCtD
Salicylic acid—Decreased appetite—Carmustine—brain cancer	0.000441	0.00591	CcSEcCtD
Salicylic acid—Somnolence—Temozolomide—brain cancer	0.000436	0.00584	CcSEcCtD
Salicylic acid—Pain—Carmustine—brain cancer	0.000434	0.00582	CcSEcCtD
Salicylic acid—Constipation—Carmustine—brain cancer	0.000434	0.00582	CcSEcCtD
Salicylic acid—Dyspepsia—Temozolomide—brain cancer	0.000431	0.00579	CcSEcCtD
Salicylic acid—Diarrhoea—Hydroxyurea—brain cancer	0.000429	0.00576	CcSEcCtD
Salicylic acid—PTGS1—pituitary gland—brain cancer	0.000429	0.00858	CbGeAlD
Salicylic acid—Decreased appetite—Temozolomide—brain cancer	0.000426	0.00571	CcSEcCtD
Salicylic acid—Pain—Temozolomide—brain cancer	0.000419	0.00562	CcSEcCtD
Salicylic acid—Constipation—Temozolomide—brain cancer	0.000419	0.00562	CcSEcCtD
Salicylic acid—Feeling abnormal—Carmustine—brain cancer	0.000418	0.00561	CcSEcCtD
Salicylic acid—ALB—brain—brain cancer	0.000417	0.00834	CbGeAlD
Salicylic acid—Dizziness—Hydroxyurea—brain cancer	0.000415	0.00556	CcSEcCtD
Salicylic acid—PTGS2—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.000415	0.0429	CbGpPWpGaD
Salicylic acid—PTGS2—pituitary gland—brain cancer	0.00041	0.0082	CbGeAlD
Salicylic acid—Feeling abnormal—Temozolomide—brain cancer	0.000404	0.00542	CcSEcCtD
Salicylic acid—SLC22A8—brain—brain cancer	0.0004	0.00801	CbGeAlD
Salicylic acid—Vomiting—Hydroxyurea—brain cancer	0.000399	0.00535	CcSEcCtD
Salicylic acid—Rash—Hydroxyurea—brain cancer	0.000396	0.00531	CcSEcCtD
Salicylic acid—Confusional state—Etoposide—brain cancer	0.000395	0.0053	CcSEcCtD
Salicylic acid—PTGS2—medulla oblongata—brain cancer	0.000395	0.00791	CbGeAlD
Salicylic acid—Dermatitis—Hydroxyurea—brain cancer	0.000395	0.0053	CcSEcCtD
Salicylic acid—Headache—Hydroxyurea—brain cancer	0.000393	0.00527	CcSEcCtD
Salicylic acid—Urticaria—Temozolomide—brain cancer	0.000389	0.00522	CcSEcCtD
Salicylic acid—Anorexia—Etoposide—brain cancer	0.000374	0.00501	CcSEcCtD
Salicylic acid—Nausea—Hydroxyurea—brain cancer	0.000373	0.005	CcSEcCtD
Salicylic acid—PTGS1—spinal cord—brain cancer	0.000369	0.00738	CbGeAlD
Salicylic acid—CYP2C9—endocrine gland—brain cancer	0.000364	0.00728	CbGeAlD
Salicylic acid—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000362	0.0374	CbGpPWpGaD
Salicylic acid—PTGS2—midbrain—brain cancer	0.000361	0.00723	CbGeAlD
Salicylic acid—PTGS2—spinal cord—brain cancer	0.000352	0.00706	CbGeAlD
Salicylic acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.000351	0.0363	CbGpPWpGaD
Salicylic acid—Somnolence—Etoposide—brain cancer	0.000349	0.00468	CcSEcCtD
Salicylic acid—Diarrhoea—Carmustine—brain cancer	0.000347	0.00465	CcSEcCtD
Salicylic acid—Pruritus—Temozolomide—brain cancer	0.000347	0.00465	CcSEcCtD
Salicylic acid—Decreased appetite—Etoposide—brain cancer	0.000341	0.00457	CcSEcCtD
Salicylic acid—Dizziness—Carmustine—brain cancer	0.000335	0.0045	CcSEcCtD
Salicylic acid—Constipation—Etoposide—brain cancer	0.000335	0.0045	CcSEcCtD
Salicylic acid—Pain—Etoposide—brain cancer	0.000335	0.0045	CcSEcCtD
Salicylic acid—Diarrhoea—Temozolomide—brain cancer	0.000335	0.0045	CcSEcCtD
Salicylic acid—PTGS1—endocrine gland—brain cancer	0.000332	0.00665	CbGeAlD
Salicylic acid—PTGS1—head—brain cancer	0.000328	0.00656	CbGeAlD
Salicylic acid—Dizziness—Temozolomide—brain cancer	0.000324	0.00435	CcSEcCtD
Salicylic acid—Feeling abnormal—Etoposide—brain cancer	0.000323	0.00434	CcSEcCtD
Salicylic acid—Vomiting—Carmustine—brain cancer	0.000322	0.00433	CcSEcCtD
Salicylic acid—Rash—Carmustine—brain cancer	0.00032	0.00429	CcSEcCtD
Salicylic acid—Dermatitis—Carmustine—brain cancer	0.000319	0.00429	CcSEcCtD
Salicylic acid—Headache—Carmustine—brain cancer	0.000318	0.00426	CcSEcCtD
Salicylic acid—PTGS2—endocrine gland—brain cancer	0.000317	0.00635	CbGeAlD
Salicylic acid—PTGS2—head—brain cancer	0.000313	0.00627	CbGeAlD
Salicylic acid—Vomiting—Temozolomide—brain cancer	0.000312	0.00418	CcSEcCtD
Salicylic acid—Urticaria—Etoposide—brain cancer	0.000312	0.00418	CcSEcCtD
Salicylic acid—ABCB1—telencephalon—brain cancer	0.000311	0.00623	CbGeAlD
Salicylic acid—Rash—Temozolomide—brain cancer	0.000309	0.00415	CcSEcCtD
Salicylic acid—Dermatitis—Temozolomide—brain cancer	0.000309	0.00414	CcSEcCtD
Salicylic acid—Headache—Temozolomide—brain cancer	0.000307	0.00412	CcSEcCtD
Salicylic acid—Nausea—Carmustine—brain cancer	0.000301	0.00404	CcSEcCtD
Salicylic acid—PTGS1—central nervous system—brain cancer	0.000299	0.00599	CbGeAlD
Salicylic acid—Nausea—Temozolomide—brain cancer	0.000291	0.0039	CcSEcCtD
Salicylic acid—PTGS2—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000287	0.0297	CbGpPWpGaD
Salicylic acid—PTGS2—central nervous system—brain cancer	0.000286	0.00572	CbGeAlD
Salicylic acid—PTGS2—cerebellum—brain cancer	0.000279	0.00559	CbGeAlD
Salicylic acid—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000278	0.0288	CbGpPWpGaD
Salicylic acid—Pruritus—Etoposide—brain cancer	0.000277	0.00372	CcSEcCtD
Salicylic acid—Diarrhoea—Etoposide—brain cancer	0.000268	0.0036	CcSEcCtD
Salicylic acid—ABCB1—gonad—brain cancer	0.00026	0.0052	CbGeAlD
Salicylic acid—Dizziness—Etoposide—brain cancer	0.000259	0.00348	CcSEcCtD
Salicylic acid—ABCB1—pituitary gland—brain cancer	0.000253	0.00507	CbGeAlD
Salicylic acid—AKR1C1—Metapathway biotransformation—CYP2C9—brain cancer	0.00025	0.0258	CbGpPWpGaD
Salicylic acid—Vomiting—Etoposide—brain cancer	0.000249	0.00334	CcSEcCtD
Salicylic acid—Rash—Etoposide—brain cancer	0.000247	0.00332	CcSEcCtD
Salicylic acid—Dermatitis—Etoposide—brain cancer	0.000247	0.00331	CcSEcCtD
Salicylic acid—Headache—Etoposide—brain cancer	0.000246	0.0033	CcSEcCtD
Salicylic acid—ABCB1—medulla oblongata—brain cancer	0.000244	0.00489	CbGeAlD
Salicylic acid—PTGS1—brain—brain cancer	0.000237	0.00475	CbGeAlD
Salicylic acid—Nausea—Etoposide—brain cancer	0.000233	0.00312	CcSEcCtD
Salicylic acid—PTGS2—brain—brain cancer	0.000227	0.00454	CbGeAlD
Salicylic acid—ABCB1—midbrain—brain cancer	0.000223	0.00447	CbGeAlD
Salicylic acid—ABCB1—spinal cord—brain cancer	0.000218	0.00436	CbGeAlD
Salicylic acid—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000199	0.0206	CbGpPWpGaD
Salicylic acid—ABCB1—endocrine gland—brain cancer	0.000196	0.00393	CbGeAlD
Salicylic acid—ABCB1—head—brain cancer	0.000194	0.00388	CbGeAlD
Salicylic acid—SLC16A1—Cell surface interactions at the vascular wall—BSG—brain cancer	0.000187	0.0193	CbGpPWpGaD
Salicylic acid—ABCB1—central nervous system—brain cancer	0.000177	0.00354	CbGeAlD
Salicylic acid—ABCB1—cerebellum—brain cancer	0.000173	0.00346	CbGeAlD
Salicylic acid—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00016	0.0166	CbGpPWpGaD
Salicylic acid—PTGS2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000158	0.0164	CbGpPWpGaD
Salicylic acid—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000153	0.0158	CbGpPWpGaD
Salicylic acid—ABCB1—brain—brain cancer	0.00014	0.00281	CbGeAlD
Salicylic acid—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00014	0.0144	CbGpPWpGaD
Salicylic acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000136	0.0141	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.73e-05	0.0101	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—DTX2—brain cancer	7.66e-05	0.00792	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—MPL—brain cancer	7.5e-05	0.00776	CbGpPWpGaD
Salicylic acid—PTGS1—Biological oxidations—CYP2C9—brain cancer	7.42e-05	0.00767	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—S100A10—brain cancer	7.19e-05	0.00744	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.11e-05	0.00736	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	7e-05	0.00725	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—S100A10—brain cancer	6.35e-05	0.00656	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—OR4C12—brain cancer	6.31e-05	0.00652	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—OR14C36—brain cancer	6.31e-05	0.00652	CbGpPWpGaD
Salicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	6.25e-05	0.00646	CbGpPWpGaD
Salicylic acid—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	6.24e-05	0.00646	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—S100A10—brain cancer	6.22e-05	0.00644	CbGpPWpGaD
Salicylic acid—SLC22A7—Fluoropyrimidine Activity—TP53—brain cancer	5.86e-05	0.00607	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—GFAP—brain cancer	5.82e-05	0.00602	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—S100A10—brain cancer	5.76e-05	0.00596	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HES5—brain cancer	5.62e-05	0.00581	CbGpPWpGaD
Salicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	5.57e-05	0.00576	CbGpPWpGaD
Salicylic acid—PTGS2—S1P1 pathway—VEGFA—brain cancer	5.44e-05	0.00563	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—DTX2—brain cancer	5.36e-05	0.00555	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—CDK6—brain cancer	5.1e-05	0.00528	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—BSG—brain cancer	5.06e-05	0.00524	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—MPL—brain cancer	4.91e-05	0.00508	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	4.84e-05	0.00501	CbGpPWpGaD
Salicylic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—brain cancer	4.56e-05	0.00472	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	4.55e-05	0.0047	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—SOD2—brain cancer	4.52e-05	0.00467	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	4.46e-05	0.00461	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—CYP2C9—brain cancer	4.33e-05	0.00448	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTCH2—brain cancer	4.06e-05	0.0042	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	4.04e-05	0.00418	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HES5—brain cancer	3.94e-05	0.00407	CbGpPWpGaD
Salicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	3.9e-05	0.00403	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STRADA—brain cancer	3.82e-05	0.00395	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IDH1—brain cancer	3.78e-05	0.00391	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—HES1—brain cancer	3.75e-05	0.00388	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—BSG—brain cancer	3.68e-05	0.00381	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—SOD2—brain cancer	3.67e-05	0.0038	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—SOD2—brain cancer	3.61e-05	0.00373	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HEY1—brain cancer	3.58e-05	0.00371	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—DLL1—brain cancer	3.52e-05	0.00364	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.5e-05	0.00363	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TRPC6—brain cancer	3.32e-05	0.00343	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.23e-05	0.00335	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ABR—brain cancer	3.19e-05	0.0033	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—IDH1—brain cancer	3.17e-05	0.00328	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.13e-05	0.00324	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—GLI2—brain cancer	3.08e-05	0.00319	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—ENO2—brain cancer	2.99e-05	0.00309	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—SHH—brain cancer	2.99e-05	0.00309	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	2.97e-05	0.00307	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	2.95e-05	0.00305	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	2.93e-05	0.00303	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—SOD2—brain cancer	2.92e-05	0.00302	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—GLI1—brain cancer	2.9e-05	0.003	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.87e-05	0.00297	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.85e-05	0.00295	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SUFU—brain cancer	2.74e-05	0.00284	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.68e-05	0.00277	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—PDGFRA—brain cancer	2.66e-05	0.00275	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	2.66e-05	0.00275	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—GFAP—brain cancer	2.65e-05	0.00274	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	2.63e-05	0.00272	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—RELA—brain cancer	2.61e-05	0.0027	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.58e-05	0.00267	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—MPL—brain cancer	2.53e-05	0.00262	CbGpPWpGaD
Salicylic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—brain cancer	2.52e-05	0.00261	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HEY1—brain cancer	2.51e-05	0.0026	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.5e-05	0.00259	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—ENO2—brain cancer	2.5e-05	0.00259	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—VAV1—brain cancer	2.49e-05	0.00257	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.47e-05	0.00255	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—DLL1—brain cancer	2.46e-05	0.00255	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—S100A10—brain cancer	2.43e-05	0.00251	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CYP2C9—brain cancer	2.41e-05	0.0025	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.41e-05	0.0025	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.26e-05	0.00234	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—CDKN2A—brain cancer	2.25e-05	0.00233	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CDK4—brain cancer	2.24e-05	0.00232	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	2.23e-05	0.00231	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	2.22e-05	0.0023	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TRPC6—brain cancer	2.17e-05	0.00225	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—VAV1—brain cancer	2.16e-05	0.00223	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—RELA—brain cancer	2.12e-05	0.0022	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	2.1e-05	0.00218	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—S100A10—brain cancer	2.1e-05	0.00217	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SHH—brain cancer	2.09e-05	0.00217	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—RELA—brain cancer	2.09e-05	0.00216	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.08e-05	0.00215	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.06e-05	0.00213	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—BSG—brain cancer	2.05e-05	0.00212	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TRPC6—brain cancer	2.02e-05	0.00209	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.02e-05	0.00209	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.99e-05	0.00206	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTCH1—brain cancer	1.98e-05	0.00205	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SMO—brain cancer	1.98e-05	0.00205	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—IL2—brain cancer	1.91e-05	0.00198	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—CCND1—brain cancer	1.9e-05	0.00197	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	1.87e-05	0.00193	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—HES1—brain cancer	1.86e-05	0.00192	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.85e-05	0.00192	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	1.84e-05	0.0019	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.83e-05	0.00189	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—DTX2—brain cancer	1.78e-05	0.00184	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	1.78e-05	0.00184	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PDGFRA—brain cancer	1.77e-05	0.00183	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—IDH1—brain cancer	1.77e-05	0.00183	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.76e-05	0.00183	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—BSG—brain cancer	1.71e-05	0.00177	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—RELA—brain cancer	1.69e-05	0.00175	CbGpPWpGaD
Salicylic acid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	1.66e-05	0.00172	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.65e-05	0.00171	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	1.63e-05	0.00168	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—NOTCH2—brain cancer	1.59e-05	0.00164	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—PIK3CG—brain cancer	1.58e-05	0.00163	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—IRS2—brain cancer	1.55e-05	0.00161	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.53e-05	0.00158	CbGpPWpGaD
Salicylic acid—PTGS2—C-MYB transcription factor network—MYC—brain cancer	1.52e-05	0.00158	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VAV1—brain cancer	1.51e-05	0.00156	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—IL2—brain cancer	1.49e-05	0.00154	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	1.46e-05	0.00151	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL2—brain cancer	1.45e-05	0.0015	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CCND1—brain cancer	1.45e-05	0.0015	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.44e-05	0.00149	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.43e-05	0.00148	CbGpPWpGaD
Salicylic acid—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.42e-05	0.00147	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.41e-05	0.00146	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ENO2—brain cancer	1.4e-05	0.00144	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—VEGFA—brain cancer	1.39e-05	0.00144	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—APC—brain cancer	1.37e-05	0.00142	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.34e-05	0.00138	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	1.33e-05	0.00137	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.31e-05	0.00136	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HES5—brain cancer	1.31e-05	0.00135	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—HES1—brain cancer	1.3e-05	0.00135	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CYP2C9—brain cancer	1.27e-05	0.00131	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.25e-05	0.00129	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PDGFRA—brain cancer	1.24e-05	0.00128	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.23e-05	0.00128	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TP53—brain cancer	1.23e-05	0.00127	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—SPP1—brain cancer	1.2e-05	0.00124	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—MYC—brain cancer	1.16e-05	0.0012	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CG—brain cancer	1.15e-05	0.00119	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—EGFR—brain cancer	1.14e-05	0.00118	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TRPC6—brain cancer	1.12e-05	0.00116	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.11e-05	0.00115	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—IL2—brain cancer	1.11e-05	0.00115	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.09e-05	0.00113	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IRS2—brain cancer	1.09e-05	0.00112	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.08e-05	0.00112	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—BSG—brain cancer	1.08e-05	0.00112	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—ERBB2—brain cancer	1.06e-05	0.0011	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.03e-05	0.00107	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.02e-05	0.00105	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP2C9—brain cancer	1.01e-05	0.00104	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.85e-06	0.00102	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.75e-06	0.00101	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	9.7e-06	0.001	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—APC—brain cancer	9.6e-06	0.000993	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CG—brain cancer	9.6e-06	0.000993	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TP53—brain cancer	9.54e-06	0.000987	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—VEGFA—brain cancer	9.44e-06	0.000977	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—CTNNB1—brain cancer	9.32e-06	0.000964	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—IDH1—brain cancer	9.28e-06	0.00096	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IDH1—brain cancer	8.79e-06	0.00091	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.59e-06	0.000888	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—BSG—brain cancer	8.56e-06	0.000886	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.49e-06	0.000879	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VAV1—brain cancer	8.39e-06	0.000868	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HEY1—brain cancer	8.34e-06	0.000862	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—DLL1—brain cancer	8.17e-06	0.000846	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2C9—brain cancer	8.15e-06	0.000843	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—STAT3—brain cancer	8.12e-06	0.00084	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.9e-06	0.000818	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.9e-06	0.000817	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.73e-06	0.000799	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.55e-06	0.000781	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—brain cancer	7.55e-06	0.000781	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RELA—brain cancer	7.5e-06	0.000776	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ERBB2—brain cancer	7.46e-06	0.000771	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EGFR—brain cancer	7.38e-06	0.000764	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—IDH1—brain cancer	7.36e-06	0.000762	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ENO2—brain cancer	7.33e-06	0.000759	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	7.27e-06	0.000753	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2C9—brain cancer	7.14e-06	0.000739	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—brain cancer	7.14e-06	0.000738	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.98e-06	0.000722	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ENO2—brain cancer	6.95e-06	0.000719	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—SHH—brain cancer	6.95e-06	0.000719	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BSG—brain cancer	6.93e-06	0.000717	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.91e-06	0.000715	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2—brain cancer	6.76e-06	0.000699	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CCND1—brain cancer	6.59e-06	0.000682	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CTNNB1—brain cancer	6.52e-06	0.000675	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.49e-06	0.000671	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CG—brain cancer	6.4e-06	0.000662	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	6.18e-06	0.00064	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.09e-06	0.00063	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BSG—brain cancer	6.07e-06	0.000628	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6e-06	0.00062	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—IDH1—brain cancer	5.96e-06	0.000616	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ENO2—brain cancer	5.82e-06	0.000602	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—brain cancer	5.74e-06	0.000594	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—brain cancer	5.69e-06	0.000588	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BSG—brain cancer	5.67e-06	0.000587	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.6e-06	0.000579	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.48e-06	0.000567	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CG—brain cancer	5.33e-06	0.000551	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—brain cancer	5.28e-06	0.000547	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—IDH1—brain cancer	5.22e-06	0.00054	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—brain cancer	5.17e-06	0.000535	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—VAV1—brain cancer	5.02e-06	0.00052	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—IDH1—brain cancer	4.88e-06	0.000504	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.85e-06	0.000502	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ENO2—brain cancer	4.71e-06	0.000487	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.6e-06	0.000476	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—brain cancer	4.34e-06	0.000449	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HES1—brain cancer	4.32e-06	0.000447	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ENO2—brain cancer	4.13e-06	0.000427	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PDGFRA—brain cancer	4.11e-06	0.000425	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.97e-06	0.000411	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ENO2—brain cancer	3.85e-06	0.000399	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—brain cancer	3.75e-06	0.000388	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—IRS2—brain cancer	3.61e-06	0.000374	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—brain cancer	3.36e-06	0.000348	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—brain cancer	3.19e-06	0.00033	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—brain cancer	3.19e-06	0.00033	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—brain cancer	2.67e-06	0.000276	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—brain cancer	2.48e-06	0.000256	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—brain cancer	2.41e-06	0.000249	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CTNNB1—brain cancer	2.17e-06	0.000224	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—brain cancer	2.16e-06	0.000224	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—brain cancer	1.89e-06	0.000196	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—brain cancer	1.89e-06	0.000195	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—brain cancer	1.77e-06	0.000183	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—brain cancer	1.75e-06	0.000182	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—brain cancer	1.72e-06	0.000178	CbGpPWpGaD
